Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-009026)

Filing Details

Accession Number:: 0000899243-20-009026
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-19 17:48:07
Reporting Period:: 2020-03-17

Accepted Time:: 2020-03-19 17:48:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1723128	Amneal Pharmaceuticals Inc.	AMRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033876	M Paul Meister	C/O Amneal Pharmaceuticals, Inc. 400 Crossing Boulevard, 3Rd Floor Bridgewater NJ 08807		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2020-03-17	149,439	$2.79	149,439	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-03-18	204,210	$2.71	353,649	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.72 to $2.85, inclusive.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.555 to $2.85, inclusive.